Anti-VEGF [Bevacizumab]

Absolute Antibody

Anti-VEGF [Bevacizumab]

7

This is a research-grade biosimilar against VEGF. VEGF is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.

Flow Cytometry, ImmunoPrecipitation, Western Blot, ELISA, Neutralisation/Blocking

ELISA; IP; WB; Block; FC

Research Use Only

Monoclonal

Bevacizumab

VEGFA

vascular endothelial growth factor A

L-VEGF, MVCD1, VEGF, VPF, vascular endothelial growth factor A, long form, vascular endothelial growth factor A121, vascular endothelial growth factor A165, vascular permeability factor

Human

IgG1

Vascular endothelial growth factor A

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Human

Recombinant human VEGF.

-20°C,2°C to 8°C

12352203